DYNC1I2

DYNC1I2 encodes an intermediate chain of the cytoplasmic dynein-1 motor complex that drives minus-end-directed microtubule transport and is required for proper mitotic spindle assembly and neurodevelopment (PMID:31079899). During embryogenesis it is broadly expressed throughout the central and peripheral nervous system, in contrast to the more restricted paralog, and produces multiple alternatively spliced isoforms whose complexity peaks in neural tissue, consistent with tissue-specific tuning of cargo-binding specificity (PMID:10049579, PMID:20657784). Its motor function is regulated by ERK, which phosphorylates a conserved serine near the binding site for the dynactin subunit p150Glued following EGF receptor stimulation; this modification does not alter p150Glued binding, indicating regulation of dynein activity through a dynactin-independent route (PMID:23434660). DYNC1I2 also supports organelle positioning: it interacts with TMEM39A to maintain perinuclear lysosome distribution, and loss of either protein disperses lysosomes to the cell periphery, impairs mTOR signaling, and activates the TFEB-like factor HLH-30 (PMID:33531362). Bi-allelic loss-of-function variants in humans cause autosomal-recessive syndromic microcephaly with cerebral malformations, and disruption in zebrafish reproduces reduced head size, abnormal mitotic spindle morphology, prolonged mitosis, and increased apoptosis, establishing that spindle defects underlie the neurodevelopmental phenotype (PMID:31079899).

1. 1999 Medium

   Establishing where the two dynein intermediate-chain paralogs act resolved whether they are redundant: DYNC1I2 shows broad nervous-system expression unlike the restricted paralog, implying distinct developmental roles.

   Evidence RNA in situ hybridization across mouse embryogenesis

   PMID:10049579

   Open questions at the time

   • Expression pattern alone does not define a molecular function
   • Functional non-redundancy with the paralog not directly tested
2. 2010 Medium

   Mapping the isoform repertoire addressed how cargo-binding diversity might be generated: DYNC1I2 undergoes complex alternative splicing with maximal complexity in nervous tissue, plus a novel promoter and non-coding exon 1.

   Evidence mRNA expression profiling across mouse tissues with cross-species bioinformatics and isoform cloning

   PMID:20657784

   Open questions at the time

   • Functional consequences of specific isoforms on cargo selection not demonstrated
   • Promoter usage not linked to a phenotype
3. 2013 High

   Identifying an ERK phosphosite addressed how signaling regulates the motor: a conserved serine near the p150Glued binding site is phosphorylated after EGF stimulation, but does not change dynactin binding, implying a dynactin-independent regulatory mechanism.

   Evidence Affinity purification, in vitro ERK kinase assay, mass spectrometry site mapping, phosphomimetic mutagenesis, and p150Glued co-immunoprecipitation in fibroblasts

   PMID:23434660

   Open questions at the time

   • The actual dynactin-independent effect of phosphorylation on dynein function not identified
   • In vivo relevance of the phosphosite not established
4. 2019 High

   Linking DYNC1I2 to human disease established its essential developmental role: bi-allelic loss-of-function causes syndromic microcephaly, and animal models traced this to spindle abnormality, prolonged mitosis, and apoptosis.

   Evidence Whole-exome sequencing of patients; CRISPR-Cas9 and morpholino disruption in zebrafish with cell-death, cell-cycle, and spindle imaging; patient-variant complementation

   PMID:31079899

   Open questions at the time

   • Molecular mechanism connecting dynein intermediate chain loss to spindle defect not dissected
   • Cargo specificity in neural progenitors not defined
5. 2021 High

   Defining a partner for organelle positioning extended DYNC1I2 function beyond mitosis: it interacts with TMEM39A to maintain perinuclear lysosomes and support mTOR signaling.

   Evidence Co-immunoprecipitation; C. elegans and mammalian knockouts; lysosome distribution imaging; mTOR and HLH-30/TFEB reporter assays

   PMID:33531362

   Open questions at the time

   • How TMEM39A couples to the dynein motor mechanistically not resolved
   • Whether lysosome mispositioning contributes to the microcephaly phenotype unknown
6. 2022 Medium

   Uncovering post-transcriptional control showed DYNC1I2 levels are actively buffered: the primate-specific lncRNA HHIP-AS1 binds its mRNA and shields it from miR-425-5p degradation, stabilizing protein in SHH-driven tumors.

   Evidence RNA pulldown/direct binding assay, miRNA functional assays, HHIP-AS1 knockdown with spindle imaging and in vivo tumorigenicity assays

   PMID:35831316

   Open questions at the time

   • This concerns regulation of DYNC1I2 mRNA, not the protein's own mechanism
   • Regulatory element not conserved in mice, limiting generalizability
7. 2026 Low

   A pharmacological neuropathy model placed DYNC1I2 in axonal mitochondrial transport: alpha-lipoic acid downregulates DYNC1I2 while upregulating the anterograde motor KIF5A via AMPK/CREB signaling.

   Evidence Western blotting and immunofluorescence in rat sciatic nerve and NSC34 cells under high glucose/palmitate with ALA treatment and AMPK/CREB pathway analysis

   PMID:41920893

   Open questions at the time

   • No direct mechanistic dissection of DYNC1I2 in transport — correlation only
   • Causal role of DYNC1I2 changes in the neuropathy phenotype not tested

• How DYNC1I2 isoform identity and ERK phosphorylation select specific cargoes, and how the spindle-assembly defect mechanistically produces microcephaly, remain unresolved.
• No structural model of how phosphorylation alters dynein function independent of dynactin
• Cargo-specific isoform functions not mapped
• Mechanistic link between spindle abnormality and neural progenitor apoptosis not defined